A Comparison of Budesonide and Mesalamine for Active Crohn's Disease
Open Access
- 6 August 1998
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (6) , 370-374
- https://doi.org/10.1056/nejm199808063390603
Abstract
Crohn's disease is often treated with glucocorticoids or mesalamine. We compared the efficacy and safety of controlled-ileal-release budesonide capsules and slow-release mesalamine tablets in patients with active Crohn's disease affecting the ileum, the ascending colon, or both.Keywords
This publication has 10 references indexed in Scilit:
- Oral budesonide is as effective as oral prednisolone in active Crohn’s diseaseGut, 1997
- A Comparison of Budesonide with Prednisolone for Active Crohn's DiseaseNew England Journal of Medicine, 1994
- Oral Budesonide for Active Crohn's DiseaseNew England Journal of Medicine, 1994
- Second trial of mesalamine therapy in the treatment of active Crohn's diseaseGastroenterology, 1994
- Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trialGastroenterology, 1993
- Oral 5-Aminosalicyclic Acid Versus 6-Methylprednisolone in Active Crohn's DiseaseCanadian Journal of Gastroenterology and Hepatology, 1990
- Overview of Newer Glucocorticosteroid Preparations for Inflammatory Bowel DiseaseCanadian Journal of Gastroenterology and Hepatology, 1990
- Slow-Release 5-Amino-Salicylic Acid (Pentasa®) for the Treatment of Active Crohn’s DiseaseDigestion, 1990
- 5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®Scandinavian Journal of Gastroenterology, 1986
- Development of a Crohn's Disease Activity IndexGastroenterology, 1976